rts logo

Which Institutions Own Shares In IN8bio Inc (INAB)?

IN8bio Inc (NASDAQ: INAB) is -18.12% lower on its value in year-to-date trading and has touched a low of $0.65 and a high of $3.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The INAB stock was last observed hovering at around $1.04 in the last trading session, with the day’s gains setting it 0.09%.

Currently trading at $1.13, the stock is 10.63% and 1.77% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.79 million and changing 8.65% at the moment leaves the stock 0.04% off its SMA200. INAB registered -54.07% loss for a year compared to 6-month loss of 7.62%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a 15.27% gain in the last 1 month and extending the period to 3 months gives it a 0.89%, and is 11.88% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.83% over the week and 6.47% over the month.

IN8bio Inc (INAB) has around 31 employees, a market worth around $49.86M and $0.00M in sales. Distance from 52-week low is 73.85% and -67.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-105.97%).

The EPS is expected to grow by 35.67% this year

The shares outstanding are 43.29M, and float is at 29.84M with Short Float at 0.60%.

IN8bio Inc (INAB) Insider Activity

The most recent transaction is an insider purchase by Graff Jeremy R., the company’s Director. SEC filings show that Graff Jeremy R. bought 2,500 shares of the company’s common stock on Sep 13 ’23 at a price of $0.95 per share for a total of $2375.0. Following the purchase, the insider now owns 2500.0 shares.

IN8bio Inc disclosed in a document filed with the SEC on Aug 25 ’23 that McCall Patrick (Chief Financial Officer) bought a total of 1,000 shares of the company’s common stock. The trade occurred on Aug 25 ’23 and was made at $1.03 per share for $1030.0. Following the transaction, the insider now directly holds 6263.0 shares of the INAB stock.

Still, SEC filings show that on Aug 24 ’23, Ho William Tai-Wei (President and CEO) acquired 23,800 shares at an average price of $1.05 for $24990.0. The insider now directly holds 2,339,545 shares of IN8bio Inc (INAB).

Related Posts